Data / Form D filings / Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc.: Form D filings
Ernexa Therapeutics Inc., a biotechnology company in Cambridge, MA, filed 10 Form D notices with the SEC between 2009 and 2025. The latest, on April 11, 2025, reports $7.2 million sold of a $7.2 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1035 CAMBRIDGE STREET, SUITE 18A, Cambridge, MA, 02141
- Phone
- (617) 798-6700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 748592
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | New notice | $7,249,999 | $7,249,999 | 15 | Mar 31, 2025 | sec.gov | |
| Nov 14, 2024 | New notice | $3,887,252 | $3,887,252 | 11 | Sep 24, 2024 | sec.gov | |
| Nov 14, 2024 | New notice | $1,137,746 | $1,137,746 | 5 | Sep 24, 2024 | sec.gov | |
| Dec 20, 2023 | New notice | $9,193,000 | $7,788,000 | $1,405,000 | 19 | Dec 15, 2023 | sec.gov |
| Jul 26, 2023 | New notice | $8,715,000 | $8,715,000 | 19 | Jul 14, 2023 | sec.gov | |
| Jul 26, 2023 | New notice | $8,715,000 | $8,715,000 | 19 | Jul 14, 2023 | sec.gov | |
| Dec 16, 2022 | New notice | $7,712,874 | $7,712,874 | 20 | Dec 2, 2022 | sec.gov | |
| Mar 23, 2022 | New notice | $12,000,000 | $12,000,000 | 1 | Mar 9, 2022 | sec.gov | |
| Nov 18, 2013 | New notice | $3,840,000 | $2,400,000 | $1,440,000 | 6 | Nov 12, 2013 | sec.gov |
| May 26, 2009 | New notice | $2,250,000 | $2,250,000 | 0 | May 11, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Cicala | Director | |
| Sandra Gurrola | Executive Officer | |
| William Wexler | Director | |
| James Bristol | Director | |
| Sanjeev Luther | Executive Officer, Director | |
| Elena Ratner | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 7, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ernexa Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.